Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2019 09:00 ET | Source: American Kidney Fund

American Kidney Fund Highlights Critical Public Health Education Programs at ASN Kidney Week, Booth #2717

WASHINGTON, D.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- At the American Society of Nephrology (ASN) Kidney Week 2019 Annual Meeting in Washington, D.C., the American Kidney Fund (AKF) is launching its...
August 26, 2019 10:08 ET | Source: American Kidney Fund

Beyond Bananas™: American Kidney Fund Launches Campaign to Help Kidney Patients Reduce Risk and Effects of Hyperkalemia

Rockville, Md., Aug. 26, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched a new health education campaign, Beyond Bananas™, to increase kidney patients’ understanding of high...
May 29, 2019 10:41 ET | Source: American Kidney Fund

American Kidney Fund and AstraZeneca Announce Campaign to Expand Education and Awareness of Hyperkalemia in Patients with Kidney Disease

Rockville, Md., May 29, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced AstraZeneca as the founding supporter to develop an education and awareness campaign that will aim...
October 22, 2018 08:00 ET | Source: Relypsa, Inc.

Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at AMCP Nexus 2018

REDWOOD CITY, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the Academy of Managed Care Pharmacy’s AMCP...
October 09, 2018 16:00 ET | Source: Relypsa, Inc.

Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at ASN Kidney Week 2018

REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the American Society of Nephrology (ASN) Kidney...
May 16, 2018 11:30 ET | Source: American Kidney Fund

American Kidney Fund Launches Comprehensive New Kidney Disease Education Portal

ROCKVILLE, Md., May 16, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund (AFK) today unveiled CKD Central, a new free online education portal offering comprehensive information and resources on...
May 08, 2018 08:00 ET | Source: Relypsa, Inc.

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

REDWOOD CITY, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced that the United States (U.S) Food and Drug Administration (FDA) approved a...
April 11, 2018 08:00 ET | Source: Relypsa, Inc.

Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at the National Kidney Foundation 2018 Spring Clinical Meetings

REDWOOD CITY, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced results from a pooled analysis of three clinical trials evaluating the effects...
April 02, 2014 09:00 ET | Source: Relypsa, Inc.

Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs

REDWOOD CITY, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of Vice...